CM
Create Medicines
Developing in vivo immunotherapies for autoimmune diseases and cancer.
About
Create Medicines is a biotechnology startup focused on developing in vivo immunotherapies. Their approach targets autoimmune diseases and cancer by leveraging the body's own immune system. The company has secured significant Series B funding to advance its research and development efforts.
Capital network
Open in Market Map editorFrequently asked
What does Create Medicines do?
Create Medicines is a biotechnology startup focused on developing in vivo immunotherapies. Their approach targets autoimmune diseases and cancer by leveraging the body's own immune system. The company has secured significant Series B funding to advance its research and development efforts.
How much funding has Create Medicines raised?
Create Medicines has raised a total of $122M in funding. The most recent round on record is Series B.
Where is Create Medicines headquartered?
Create Medicines is headquartered in Cambridge, Massachusetts, USA.
What industry does Create Medicines operate in?
Create Medicines operates in Biotechnology, HealthTech, Pharmaceuticals.